A newly released Global Antimicrobial Resistance Surveillance Report 2025 highlights widening disparities, with low and middle-income nations disproportionately affected. According to the report, resistance was most prevalent in the WHO South-East Asia and Eastern Mediterranean regions in 20
New global estimates show that in 2019, nearly 5 million human deaths worldwide were associated with bacterial AMR, of which 1.3 million human deaths were directly attributable to bacterial AMR. In a high-impact scenario, AMR will reduce global annual GDP by 3.8 per cent by 2050.